US Patent Issued to LANTMANNEN MEDICAL on March 24 for "Antisecretory factor for use in treatment and/or prevention of acute respiratory failure" (Swedish Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,697, issued on March 24, was assigned to LANTMANNEN MEDICAL AB (Stockholm).

"Antisecretory factor for use in treatment and/or prevention of acute respiratory failure" was invented by Anders Larsson (Stockholm).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of antisecretory factor (AF) protein, homologues, and/or fragments thereof, having equivalent functional activity, and/or a pharmaceutically active salt thereof, for restoring and/or normalizing epithelial barrier function for treating and/or preventing acute respiratory failure.In particular, antisecretory factor (AF) protein, homologues, and/or fragments ...